Promised but Not Delivered: The Hidden Barriers Keeping New Yorkers Off PrEP

New York City has long positioned itself as a national leader in HIV prevention. The city launched the Ending the Epidemic initiative more than a decade ago. Public health campaigns blanket subway cars and bus shelters. PrEP — pre-exposure prophylaxis, the daily medication that reduces HIV transmission risk by up to 99 percent when taken consistently — is widely discussed in clinical and advocacy spaces alike. And yet, for tens of thousands of New Yorkers who could benefit from this medication, the distance between awareness and access remains vast, and in many cases, insurmountable.

The gap is not a matter of ignorance. It is a matter of systems.

What the Numbers Reveal

According to data from the New York City Department of Health and Mental Hygiene, an estimated 100,000 New Yorkers are strong candidates for PrEP based on their risk factors and sexual health history. Fewer than half that number are currently prescribed it. The disparity is especially pronounced among Black and Latino residents, who account for the majority of new HIV diagnoses in the city but remain significantly underrepresented among PrEP users.

These numbers do not reflect a lack of desire. Advocates and clinicians working in communities across the five boroughs consistently report that patients want access to preventive care — but that the pathway to obtaining it is riddled with obstacles that compound upon one another.

The Insurance Labyrinth

For many New Yorkers, the first barrier appears before they ever speak with a pharmacist. Insurance coverage for PrEP, while mandated under the Affordable Care Act for most plans, is far from seamless in practice. Prior authorization requirements, narrow formularies, and mid-year plan changes can interrupt a prescription before it is ever filled. Patients on Medicaid managed care plans sometimes discover that their specific insurer does not cover the brand their provider prescribed — or that the appeals process will take weeks they cannot afford to wait.

"I had a patient who came in motivated, ready to start," said one nurse practitioner at a community health center in the South Bronx, who asked not to be named due to her employer's media policy. "By the time we sorted out the coverage issue, she had moved twice, changed her phone number, and we lost her to follow-up. That happens more than people realize."

The federal Ready, Set, PrEP program offers the medication at no cost to uninsured individuals, and Gilead's patient assistance programs exist for those on limited incomes. But navigating these options requires time, internet access, documentation, and a level of health literacy that many patients — particularly those experiencing housing instability or working multiple jobs — simply cannot spare.

Pharmacy Deserts and the Outer Borough Divide

Even when a prescription is secured, filling it can pose its own challenge. A 2023 analysis of pharmacy access in New York City found significant disparities between Manhattan and the outer boroughs, with parts of eastern Queens, the North Bronx, and Staten Island's North Shore classified as pharmacy deserts — areas where residents must travel considerable distances to reach a dispensing location.

This geography matters enormously for PrEP adherence. The medication is most effective when taken consistently, and even brief interruptions in supply can create anxiety, confusion, and ultimately discontinuation. For residents relying on public transit, a round trip to a distant pharmacy is not a minor inconvenience — it is a half-day commitment that may conflict with work, childcare, or other obligations.

Mail-order pharmacy options exist, but they introduce their own complications: the need for a stable mailing address, privacy concerns for individuals who have not disclosed their sexual behavior to family members they live with, and the anxiety of waiting for a package that may or may not arrive on time.

The Weight of Stigma

Perhaps the least visible barrier is also the most pervasive. Stigma — attached both to HIV itself and to the sexual behaviors associated with PrEP use — continues to deter New Yorkers from initiating conversations with their healthcare providers, even when those providers are ostensibly affirming.

For many patients, asking about PrEP requires disclosing aspects of their sexual lives that they may not feel safe sharing. This is particularly true for Black gay and bisexual men navigating religious communities or family structures in which same-sex relationships are not accepted. It is equally true for women — a population that remains dramatically underprescribed PrEP despite accounting for a meaningful share of new diagnoses — who report that providers rarely raise the subject proactively.

"Women are not being offered PrEP the way men are," said Danielle Ruffin, a patient advocate who works with a harm reduction organization in Brooklyn. "A woman comes in for her annual exam and nobody asks her about her risk. Nobody hands her a brochure. The assumption is that PrEP is for gay men, and that assumption is costing lives."

Transgender individuals face compounding layers of stigma, including concerns about drug interactions with gender-affirming hormone therapy — interactions that research has largely found to be minimal, but that providers may not feel equipped to discuss.

What Systemic Solutions Look Like

Advocates are not short of ideas. The proposals most frequently cited by clinicians, community organizations, and affected individuals include expanding telehealth prescribing for PrEP to reduce the burden of in-person visits; integrating PrEP navigation services into existing community-based organizations rather than relying solely on clinical settings; training pharmacists to prescribe PrEP directly, as is already permitted in several states; and funding outreach workers who can meet people where they are — in barbershops, community centers, houses of worship, and shelters.

New York State took a meaningful step in 2023 by allowing pharmacists to prescribe PrEP without a physician referral. Implementation, however, has been uneven, and many pharmacists report feeling undertrained for the role.

At the federal level, the proposed Ending the HIV Epidemic initiative has allocated funding for PrEP navigation, but advocates argue that disbursement has been slow and that community organizations on the ground are chronically underfunded relative to the scale of the need.

The City We Claim to Be

New York City has the infrastructure, the expertise, and the public health mandate to make PrEP genuinely accessible to every resident who needs it. What it lacks, critics argue, is the political will to treat prevention access as the equity issue it fundamentally is.

Every New Yorker who wants PrEP should be able to get it — without fighting their insurance company, without traveling across a borough, and without risking their privacy or dignity in the process. Until those conditions are met, the city's prevention commitments remain aspirational rather than actual.

If you are interested in starting PrEP or learning more about your options, AIDS NYC maintains a directory of affirming providers and navigation resources at aidsnyc.org. No one should have to figure this out alone.